📰 Nasdaq Eldn News
Page 2 - Nasdaq Eldn News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Nasdaq Eldn. Real-time updates on events, politics, business and more.
May 11, 2023
Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN – Get Rating) saw a significant growth in short interest in the month of April. As of April 30th, there was short interest totalling 57,200 shares, a growth of 276.3% from the April 15th total of 15,200 shares. Based on an average daily volume of 122,400 shares, the short-interest ratio is […]
May 10, 2023
Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN – Get Rating) was the recipient of a significant growth in short interest in the month of April. As of April 30th, there was short interest totalling 57,200 shares, a growth of 276.3% from the April 15th total of 15,200 shares. Based on an average daily volume of 122,400 shares, the […]
May 3, 2023
Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN – Get Rating) – Stock analysts at SVB Leerink issued their Q1 2023 earnings estimates for Eledon Pharmaceuticals in a research note issued to investors on Tuesday, May 2nd. SVB Leerink analyst T. Smith expects that the company will earn ($0.71) per share for the quarter. The consensus estimate for Eledon […]
April 29, 2023
Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN – Get Rating) was the target of a large decrease in short interest in April. As of April 15th, there was short interest totalling 15,200 shares, a decrease of 47.0% from the March 31st total of 28,700 shares. Approximately 0.1% of the shares of the stock are sold short. Based on […]
April 28, 2023
Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN – Get Rating) saw a large decline in short interest during the month of April. As of April 15th, there was short interest totalling 15,200 shares, a decline of 47.0% from the March 31st total of 28,700 shares. Based on an average daily volume of 26,700 shares, the short-interest ratio is […]
April 17, 2023
Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN – Get Rating) was the target of a significant increase in short interest in the month of March. As of March 31st, there was short interest totalling 28,700 shares, an increase of 64.9% from the March 15th total of 17,400 shares. Based on an average daily trading volume, of 25,700 shares, […]
April 15, 2023
Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN – Get Rating)’s stock price traded down 4.3% during mid-day trading on Friday . The company traded as low as $2.40 and last traded at $2.44. 11,463 shares were traded during trading, a decline of 55% from the average session volume of 25,521 shares. The stock had previously closed at $2.55. […]
December 21, 2022
Eledon to Incorporate the iBox Scoring System in Future Kidney Transplant Trials...
June 11, 2022
Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN – Get Rating) was the recipient of a large increase in short interest during the month of May. As of May 31st, there was short interest totalling 39,900 shares, an increase of 250.0% from the May 15th total of 11,400 shares. Currently, 0.3% of the company’s shares are sold short. Based […]
June 2, 2022
Eledon Pharmaceuticals (NASDAQ:ELDN – Get Rating) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research note issued to investors on Wednesday, Zacks.com reports. According to Zacks, “Eledon Pharmaceuticals Inc. is a clinical stage biotechnology company. It develop treatments for an organ or cell-based transplant, and for people […]